Status:
UNKNOWN
Role of DcR3 in T Cell Activation in SLE and RA
Lead Sponsor:
National Taiwan University Hospital
Conditions:
SLE
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Decoy receptor 3 (DcR3), a new member of tumor necrosis factor receptor (TNFR) superfamily, is a decoy receptor for FasL and could inhibit FasL-induced apoptosis, has recently been shown to induce cos...
Detailed Description
Specific Aim 1. Study DcR3-induced T cell activation in SLE and RA. A. Patients and controls Patients with SLE and RA in Department of Internal Medicine, National Taiwan University Hospital will be st...
Eligibility Criteria
Inclusion
- SLE, RA
Exclusion
- nil
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
December 1 2007
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00275899
Start Date
January 1 2006
End Date
December 1 2007
Last Update
January 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan